[s2e12] A Rose By Any Other Name 〈2026 Update〉

This is a turning point for Julian Booth as she realizes the company she represents is fundamentally dishonest.

This episode of The Resident (Season 2, Episode 12) is a high-stakes look at the intersection of medical innovation and corporate greed. It balances a tense surgical thriller with a deep dive into the ethics of the medical device industry. The Quovadis Quagmire [S2E12] A Rose by Any Other Name

The central conflict revolves around the "VNS" (Vagus Nerve Stimulator) produced by Quovadis. The show does an excellent job of depicting how a "miracle cure" can quickly turn into a liability. This is a turning point for Julian Booth

To help you dive deeper into this season or the show's medical accuracy: The Quovadis Quagmire The central conflict revolves around

The device causes a patient to flatline during what should be a routine check.

Gordon Page’s desperate attempts to silence dissent show the dark side of healthcare capitalism.